Lataa...
Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: Results from a prospective real‐world observational study in the United Kingdom
OBJECTIVES: The Medicines and Healthcare Products Regulatory Agency in the United Kingdom (UK) formally reclassified sildenafil citrate 50 mg tablets as a pharmacy medicine (sildenafil‐P) in 2017 for adult men with erectile dysfunction (ED). A 1‐year prospective real‐world observational study was co...
Tallennettuna:
| Julkaisussa: | Int J Clin Pract |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8047876/ https://ncbi.nlm.nih.gov/pubmed/33220087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.13849 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|